$98.3 M

CSBR Mkt cap, 22-May-2019
Champions Oncology Net income (Q3, 2019)-369 K
Champions Oncology EBIT (Q3, 2019)-370 K
Champions Oncology Cash, 31-Jan-20193.3 M

Champions Oncology Income Statement

Champions Oncology Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

5.9m9.4m3.3m856.0k

Accounts Receivable

1.3m1.1m1.3m2.3m3.9m

Inventories

383.0k346.0k443.0k

Current Assets

7.6m10.8m4.3m5.9m5.1m

PP&E

434.0k452.0k618.0k1.2m2.1m

Goodwill

669.0k669.0k669.0k669.0k669.0k

Total Assets

8.9m12.0m5.8m8.0m8.1m

Accounts Payable

981.0k1.4m1.9m1.9m2.2m

Short-term debt

Current Liabilities

3.7m3.8m5.3m7.4m7.5m

Long-term debt

Total Debt

Total Liabilities

5.7m4.0m5.5m7.6m8.1m

Additional Paid-in Capital

43.3m61.2m63.9m71.0m72.1m

Retained Earnings

(38.9m)(52.0m)(62.5m)(69.3m)(70.8m)

Total Equity

3.2m8.1m238.0k400.0k3.0k

Financial Leverage

2.8 x1.5 x24.3 x20 x2.7 k x

Champions Oncology Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(7.4m)(13.1m)(10.4m)(6.9m)(1.5m)

Depreciation and Amortization

213.0k214.0k156.0k168.0k360.0k

Accounts Receivable

(825.0k)265.0k(282.0k)(986.0k)(1.6m)

Inventories

Accounts Payable

(223.0k)433.0k482.0k(43.0k)301.0k

Cash From Operating Activities

(3.4m)(9.6m)(6.5m)(2.8m)(1.2m)

Purchases of PP&E

(234.0k)(119.0k)(322.0k)(766.0k)(1.2m)

Cash From Investing Activities

(234.0k)(114.0k)(322.0k)(766.0k)(1.2m)

Cash From Financing Activities

21.0k13.2m2.0k4.3m13.0k

Champions Oncology Ratios

USDY, 2019

Financial Leverage

4.7 x

Champions Oncology Employee Rating

2.916 votes
Culture & Values
2.6
Work/Life Balance
3.0
Senior Management
2.8
Salary & Benefits
2.9
Career Opportunities
3.0
Source